Insider trade

Procter & Gamble (PG)CEO sold ~$5.86M

Gary A Coombe, CEO at Procter & Gamble, sold ~$5.86M of Procter & Gamble shares.

~$5.86M
Approx. value · 36K sh @ $162.33
35K
Holds after · shares reported
Traded
Feb 12, 2026
Filed
Feb 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 16, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  2. Nov 18, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  3. Dec 1, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
  4. Dec 15, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 9, 2025, Jennifer Davis, currently Chief Executive Officer - Health Care, notified the Company of her intent to retire effective June 30, 2026, after more than 33 years of service.”
  5. Dec 18, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
  6. Dec 24, 2025CongressDisclosed partial sale of PG — reported range $1,001 - $15,000
  7. Jan 9, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  8. Jan 22, 2026Company filing · Form 8-K · ResultsReported its results
  9. Jan 23, 2026InsiderOfficer sold ~$14.5M of PG shares in the open market
  10. Jan 29, 2026CongressDisclosed sale of PG — reported range $1,001 - $15,000
  11. Jan 30, 2026CongressDisclosed partial sale of PG — reported range $1,001 - $15,000
  12. Feb 2, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  13. Feb 4, 2026InsiderCEO sold ~$1.26M of PG shares in the open market
  14. Feb 9, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  15. Feb 11, 2026Insider · 2 peopleInsiders: 2 sales (~$3.8M)
  16. Feb 12, 2026 · this disclosureInsiderCEO sold ~$5.86M of PG shares in the open market

What came next

  1. Feb 12, 2026InsiderChair sold ~$26.4M of PG shares in the open market
  2. Feb 13, 2026Insider · Their largest sale since 2021Officer sold ~$2.46M of PG shares in the open market
  3. Feb 17, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  4. Feb 19, 2026InsiderOfficer sold ~$288K of PG shares in the open market
  5. Feb 26, 2026Congress · 2 peopleMembers of Congress: 2 sales
  6. Feb 27, 2026Insider · 1 personInsiders: 4 sales (~$917K)
  7. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  8. Apr 16, 2026CongressDisclosed sale of PG — reported range $15,001 - $50,000
  9. Apr 24, 2026Company filing · Form 8-K · ResultsReported its results
  10. Apr 27, 2026Congress · 1 personMembers of Congress: 2 purchases
  11. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  12. May 15, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Procter & Gamble

For Procter & Gamble, OQRO holds 21 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports and 117 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PG page.

Other recent filings by Gary A Coombe, CEO - Grooming

The full history of Gary A Coombe, CEO - Grooming is on the profile page.

How this filing works

Other disclosures at Procter & Gamble

Everything OQRO holds on this company is on its PG page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data